An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to users administering products of unknown origin.
Several experts stated the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.
Service Response and Content Elimination
Based on the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, filled with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.
Within minutes of joining one community, a seller shared contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these communities, messages show dark colored packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly significant medical dangers”.
